Vimarsana
Biggest News Aggregation in the World

Page 16 - Main Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Main Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Main Board Today - Breaking & Trending Today

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates - Vimarsana News

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...

Half-year Report | Company Announcement - Vimarsana News

Half-year Report | Company Announcement

Investegate announcements from Half-year Report

Response to Press Speculation | Company Announcement - Vimarsana News

Response to Press Speculation | Company Announcement

Investegate announcements from Response to Press Speculation

Our Legacy Creations : Melco Resorts & Entertainment Partners with Our Legacy Creations to Remount the Acclaimed 'The House of Dancing Water' Show - Vimarsana News

Our Legacy Creations : Melco Resorts & Entertainment Partners with Our Legacy Creations to Remount the Acclaimed 'The House of Dancing Water' Show

MACAU, MACAO / ACCESSWIRE / May 23, 2024 / Melco Resorts & Entertainment (Melco) has officially entrusted Our Legacy Creations (OLC) with the prestigious task of remounting its iconic resident spectacle

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016 - Vimarsana News

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016

SUZHOU, China, May 22, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I…